Comparison of cardiovascular events in patients with metastatic hormone sensitive prostate cancer treated with LHRH agonists to LHRH antagonists in the US: A retrospective cohort study
Publication date: Available online 18 October 2026 Source: Urologic Oncology: Seminars and Original Investigations Author(s): Renil S. Titus, Eusebio Luna Velasquez, Vatsala Mundra, Carlos Riveros, Sanjana Ranganathan, David-Dan Nguyen, Amar Singh, Aamuktha Porika, Dharam Kaushik, Kershaw V. Patel, Eleni Efstathiou, Christopher J.D. Wallis, Raj Satkunasivam
Comparison of cardiovascular events in patients with metastatic hormone sensitive prostate cancer treated with LHRH agonists to LHRH antagonists in the US: A retrospective cohort study. // Urologic Oncology: Seminars and Original Investigations. – URL: https://www.sciencedirect.com/science/article/pii/S1078143926007428?dgcid=rss_sd_all
Comparison of cardiovascular events in patients with metastatic hormone sensitive prostate cancer treated with LHRH agonists to LHRH antagonists in the US: A retrospective cohort study. Urologic Oncology: Seminars and Original Investigations. https://www.sciencedirect.com/science/article/pii/S1078143926007428?dgcid=rss_sd_all
“Comparison of cardiovascular events in patients with metastatic hormone sensitive prostate cancer treated with LHRH agonists to LHRH antagonists in the US: A retrospective cohort study.” Urologic Oncology: Seminars and Original Investigations.
@article{article91103,
title = {Comparison of cardiovascular events in patients with metastatic hormone sensitive prostate cancer treated with LHRH agonists to LHRH antagonists in the US: A retrospective cohort study},
journal = {Urologic Oncology: Seminars and Original Investigations},
url = {https://www.sciencedirect.com/science/article/pii/S1078143926007428?dgcid=rss_sd_all}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment